Cargando…

P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA

Detalles Bibliográficos
Autores principales: POWER-HAYS, A., R., NAMAZZI, C., KATO, A., CONROY, H., HUME, C., JOHN, S., STUBER, MA, A., LANE, T., LATHAM, R., OPOKA, R., WARE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429761/
http://dx.doi.org/10.1097/01.HS9.0000873052.78363.19
_version_ 1784779558533201920
author POWER-HAYS, A.
R., NAMAZZI
C., KATO
A., CONROY
H., HUME
C., JOHN
S., STUBER, MA
A., LANE
T., LATHAM
R., OPOKA
R., WARE
author_facet POWER-HAYS, A.
R., NAMAZZI
C., KATO
A., CONROY
H., HUME
C., JOHN
S., STUBER, MA
A., LANE
T., LATHAM
R., OPOKA
R., WARE
author_sort POWER-HAYS, A.
collection PubMed
description
format Online
Article
Text
id pubmed-9429761
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94297612022-09-01 P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA POWER-HAYS, A. R., NAMAZZI C., KATO A., CONROY H., HUME C., JOHN S., STUBER, MA A., LANE T., LATHAM R., OPOKA R., WARE Hemasphere Poster Presentations Lippincott Williams & Wilkins 2022-08-16 /pmc/articles/PMC9429761/ http://dx.doi.org/10.1097/01.HS9.0000873052.78363.19 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Poster Presentations
POWER-HAYS, A.
R., NAMAZZI
C., KATO
A., CONROY
H., HUME
C., JOHN
S., STUBER, MA
A., LANE
T., LATHAM
R., OPOKA
R., WARE
P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA
title P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA
title_full P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA
title_fullStr P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA
title_full_unstemmed P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA
title_short P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA
title_sort p-039: alternative dosing and prevention of transfusions (adapt): a prospective trial evaluating transfusion utilization and the feasibility of pharmacokinetic hydroxyurea dosing in children with sickle cell anemia in uganda
topic Poster Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429761/
http://dx.doi.org/10.1097/01.HS9.0000873052.78363.19
work_keys_str_mv AT powerhaysa p039alternativedosingandpreventionoftransfusionsadaptaprospectivetrialevaluatingtransfusionutilizationandthefeasibilityofpharmacokinetichydroxyureadosinginchildrenwithsicklecellanemiainuganda
AT rnamazzi p039alternativedosingandpreventionoftransfusionsadaptaprospectivetrialevaluatingtransfusionutilizationandthefeasibilityofpharmacokinetichydroxyureadosinginchildrenwithsicklecellanemiainuganda
AT ckato p039alternativedosingandpreventionoftransfusionsadaptaprospectivetrialevaluatingtransfusionutilizationandthefeasibilityofpharmacokinetichydroxyureadosinginchildrenwithsicklecellanemiainuganda
AT aconroy p039alternativedosingandpreventionoftransfusionsadaptaprospectivetrialevaluatingtransfusionutilizationandthefeasibilityofpharmacokinetichydroxyureadosinginchildrenwithsicklecellanemiainuganda
AT hhume p039alternativedosingandpreventionoftransfusionsadaptaprospectivetrialevaluatingtransfusionutilizationandthefeasibilityofpharmacokinetichydroxyureadosinginchildrenwithsicklecellanemiainuganda
AT cjohn p039alternativedosingandpreventionoftransfusionsadaptaprospectivetrialevaluatingtransfusionutilizationandthefeasibilityofpharmacokinetichydroxyureadosinginchildrenwithsicklecellanemiainuganda
AT sstuberma p039alternativedosingandpreventionoftransfusionsadaptaprospectivetrialevaluatingtransfusionutilizationandthefeasibilityofpharmacokinetichydroxyureadosinginchildrenwithsicklecellanemiainuganda
AT alane p039alternativedosingandpreventionoftransfusionsadaptaprospectivetrialevaluatingtransfusionutilizationandthefeasibilityofpharmacokinetichydroxyureadosinginchildrenwithsicklecellanemiainuganda
AT tlatham p039alternativedosingandpreventionoftransfusionsadaptaprospectivetrialevaluatingtransfusionutilizationandthefeasibilityofpharmacokinetichydroxyureadosinginchildrenwithsicklecellanemiainuganda
AT ropoka p039alternativedosingandpreventionoftransfusionsadaptaprospectivetrialevaluatingtransfusionutilizationandthefeasibilityofpharmacokinetichydroxyureadosinginchildrenwithsicklecellanemiainuganda
AT rware p039alternativedosingandpreventionoftransfusionsadaptaprospectivetrialevaluatingtransfusionutilizationandthefeasibilityofpharmacokinetichydroxyureadosinginchildrenwithsicklecellanemiainuganda